Potential oncogenic properties of mobilized stem cells in a subpopulation of inflammatory bowel disease patients infected with helicobacter pylori

Inflammatory Bowel Diseases

Volumn 19, Issue 2, 2013, Pages

  Kapetanakis, Nikolaos ^a   Kountouras, Jannis ^a   Zavos, Christos ^a   Anastasiadou, Kyriaki ^a   Tsarouchas, George ^a   Michael, Stavros ^a   Gavalas, Emmanuel ^a   Tsiaousi, Elena ^a   Polyzos, Stergios A ^a   Venizelos, Ioannis ^a   Nikolaidou, Christina ^a   Vardaka, Elizabeth ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; HERMES ANTIGEN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; VACUOLATING TOXIN;

ANTIGEN EXPRESSION; CARCINOGENESIS; CELL RENEWAL; COLON MUCOSA; COLORECTAL CANCER; DYSPLASIA; ENTERITIS; ESOPHAGEAL ADENOCARCINOMA; GASTROINTESTINAL CARCINOMA; HELICOBACTER INFECTION; HUMAN; HYPERPLASIA; KAPOSI SARCOMA; LETTER; METAPLASIA; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; STEM CELL MOBILIZATION; STOMACH CANCER;

BIOLOGICAL MARKERS; CROHN DISEASE; EMBRYONIC STEM CELLS; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; INTESTINES; MALE; MESENCHYMAL STROMAL CELLS;

EID: 84876419787     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.22911     Document Type: Letter

References (8)

1. MarliczW, Zuba-Surma E, Kucia M, et al. Various types of stem cells, including a population of very small embryonic-like stem cells, are mobilized into peripheral blood in patients with Crohn's disease. Inflamm Bowel Dis. 2012;18:1711-1722.
2. Piodi LP, Bardella M, Rocchia C, et al. Possible protective effect of 5-aminosalicylic acid on Helicobacter pylori infection in patients with inflammatory bowel disease. J Clin Gastroenterol. 2003;36:22-25.
3. Oliveira AG, Rocha GA, Rocha AM, et al. Isolation of Helicobacter pylori from the intestinal mucosa of patients with Crohn's disease. Helicobacter. 2006; 11:2-9.
4. Pilpilidis I, Kountouras J, Zavos C, et al. Upper gastrointestinal carcinogenesis: H. pylori and stem cell cross-talk. J Surg Res. 2011;166:255-264.
5. Kountouras J, Zavos C, Chatzopoulos D, et al. New aspects of Helicobacter pylori infection involvement in gastric oncogenesis. J Surg Res. 2008;146: 149-158.
6. Sackstein R. The biology of CD44 and HCELL in hematopoiesis: the 'step 2-bypass pathway' and other emerging perspectives. Curr Opin Hematol. 2011;18: 239-248.
7. Kapetanakis N, Kounturas J, Venizelos I, et al. Correlation between H. pylori infection and glycoprotein CD44 in colorectal carcinoma. Ann Gastroenterol. 2008;21(Suppl):25 (in Greek).
8. Kountouras J, Touloumis L, Karatzoglou P, et al. In situ H. pylori infection and oncogenes' expression in patients with colorectal cancer. Gut. 2004;53(Suppl VI):A270.Inflamm Bowel Dis.